{"count": 8, "results": [{"_id": "38004062", "pmid": 38004062, "pmcid": "PMC10673571", "title": "Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus", "journal": "Medicina (Kaunas)", "authors": ["Grigoriadis G", "Koufakis T", "Kotsa K"], "date": "2023-11-16T00:00:00Z", "doi": "10.3390/medicina59112013", "meta_date_publication": "2023 Nov 16", "meta_volume": "59", "meta_issue": "11", "meta_pages": "", "score": 50258.63, "text_hl": "@DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@Hyperinsulinemia@@@ can affect the morphology of the thyroid gland by promoting the proliferation of thyroid tissue and increasing the size of thyroid nodules. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can confer benefits in both @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathies@@@, while other antidiabetics, such as @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, can negatively affect thyroid function. ", "citations": {"NLM": "Grigoriadis G, Koufakis T, Kotsa K. Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus Medicina (Kaunas). 2023 Nov 16;59(11):. PMID: 38004062", "BibTeX": "@article{38004062, title={Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus}, author={Grigoriadis G and Koufakis T and Kotsa K}, journal={Medicina (Kaunas)}, volume={59}, number={11}}"}}, {"_id": "17367265", "pmid": 17367265, "title": "Metformin before and during pregnancy and lactation in polycystic ovary syndrome.", "journal": "Expert Opin Drug Saf", "authors": ["Glueck CJ", "Wang P"], "date": "2007-03-01T00:00:00Z", "doi": "10.1517/14740338.6.2.191", "meta_date_publication": "2007 Mar", "meta_volume": "6", "meta_issue": "2", "meta_pages": "191-8", "score": 50062.773, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves the @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@), facilitates conception, appears to reduce first trimester @DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@miscarriage@@@ and @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational diabetes@@@ and does not appear to be @DISEASE_Isotretinoin_embryopathy_like_syndrome @DISEASE_MESH:C535542 @@@teratogenic@@@. ", "citations": {"NLM": "Glueck CJ, Wang P. Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin Drug Saf. 2007 Mar;6(2):191-8. PMID: 17367265", "BibTeX": "@article{17367265, title={Metformin before and during pregnancy and lactation in polycystic ovary syndrome.}, author={Glueck CJ and Wang P}, journal={Expert Opin Drug Saf}, volume={6}, number={2}, pages={191-8}}"}}, {"_id": "11727360", "pmid": 11727360, "title": "Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.", "journal": "Gynecol Endocrinol", "authors": ["Nardo LG", "Rai R"], "date": "2001-10-01T00:00:00Z", "doi": "10.1080/gye.15.5.373.380", "meta_date_publication": "2001 Oct", "meta_volume": "15", "meta_issue": "5", "meta_pages": "373-80", "score": 50057.562, "text_hl": "Recent studies report that @GENE_INS @GENE_3630 @@@insulin@@@-sensitizing agents, such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, reduce @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyperinsulinemia@@@, reverse the @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ and normalize @DISEASE_Endocrine_System_Diseases @DISEASE_MESH:D004700 @@@endocrine@@@, metabolic and reproductive functions, leading to the resumption of menstrual cyclicity and ovulation. ", "citations": {"NLM": "Nardo LG, Rai R. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects. Gynecol Endocrinol. 2001 Oct;15(5):373-80. PMID: 11727360", "BibTeX": "@article{11727360, title={Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.}, author={Nardo LG and Rai R}, journal={Gynecol Endocrinol}, volume={15}, number={5}, pages={373-80}}"}}, {"_id": "19960891", "pmid": 19960891, "title": "Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.", "journal": "J Pediatr Endocrinol Metab", "authors": ["Glueck CJ", "Goldenberg N", "Wang P"], "date": "2009-09-01T00:00:00Z", "doi": "10.1515/jpem.2009.22.9.815", "meta_date_publication": "2009 Sep", "meta_volume": "22", "meta_issue": "9", "meta_pages": "815-26", "score": 50056.395, "text_hl": "CONCLUSIONS: In adolescents (< or = age 17 yr) with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-diet safely ameliorates @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@CHD@@@ risk factors and @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ while facilitating resumption of regular menses.", "citations": {"NLM": "Glueck CJ, Goldenberg N, Wang P. Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2009 Sep;22(9):815-26. PMID: 19960891", "BibTeX": "@article{19960891, title={Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.}, author={Glueck CJ and Goldenberg N and Wang P}, journal={J Pediatr Endocrinol Metab}, volume={22}, number={9}, pages={815-26}}"}}, {"_id": "18277353", "pmid": 18277353, "title": "Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.", "journal": "Minerva Ginecol", "authors": ["Goldenberg N", "Glueck C"], "date": "2008-02-01T00:00:00Z", "meta_date_publication": "2008 Feb", "meta_volume": "60", "meta_issue": "1", "meta_pages": "63-75", "score": 50055.93, "text_hl": "Reduction of @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyperinsulinemia@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-diet is associated not only with improvement of the biochemical @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@, but, commonly, with restoration of menstrual cycles and fertility. ", "citations": {"NLM": "Goldenberg N, Glueck C. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva Ginecol. 2008 Feb;60(1):63-75. PMID: 18277353", "BibTeX": "@article{18277353, title={Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.}, author={Goldenberg N and Glueck C}, journal={Minerva Ginecol}, volume={60}, number={1}, pages={63-75}}"}}, {"_id": "10206447", "pmid": 10206447, "title": "Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.", "journal": "Metabolism", "authors": ["Glueck CJ", "Wang P", "Fontaine R", "Tracy T", "Sieve-Smith L"], "date": "1999-04-01T00:00:00Z", "doi": "10.1016/s0026-0495(99)90113-0", "meta_date_publication": "1999 Apr", "meta_volume": "48", "meta_issue": "4", "meta_pages": "511-9", "score": 50049.88, "text_hl": "@SPECIES_9606 @@@Patients@@@ were more likely than normal controls (83% v 64%, P=.016) to be heterozygous or homozygous for 4G polymorphism of the @GENE_SERPINE1 @GENE_5054 @@@PAI-1@@@ gene and were also more likely to have high PAI-Fx (> or =22 U/mL, 28% v3%, chi(2)=10.1, P=.001). @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces the @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, allowing resumption of normal menses in most (91%) previously amenorrheic @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@.", "citations": {"NLM": "Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism. 1999 Apr;48(4):511-9. PMID: 10206447", "BibTeX": "@article{10206447, title={Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.}, author={Glueck CJ and Wang P and Fontaine R and Tracy T and Sieve-Smith L}, journal={Metabolism}, volume={48}, number={4}, pages={511-9}}"}}, {"_id": "10927066", "pmid": 10927066, "title": "Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.", "journal": "Fertil Steril", "authors": ["Glueck CJ", "Awadalla SG", "Phillips H", "Cameron D", "Wang P", "Fontaine RN"], "date": "2000-08-01T00:00:00Z", "doi": "10.1016/s0015-0282(00)00630-0", "meta_date_publication": "2000 Aug", "meta_volume": "74", "meta_issue": "2", "meta_pages": "394-7", "score": 50049.72, "text_hl": "CONCLUSION(S): @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reversed the @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@. ", "citations": {"NLM": "Glueck CJ, Awadalla SG, Phillips H, Cameron D, Wang P, Fontaine RN. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril. 2000 Aug;74(2):394-7. PMID: 10927066", "BibTeX": "@article{10927066, title={Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.}, author={Glueck CJ and Awadalla SG and Phillips H and Cameron D and Wang P and Fontaine RN}, journal={Fertil Steril}, volume={74}, number={2}, pages={394-7}}"}}, {"_id": "11524214", "pmid": 11524214, "title": "Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).", "journal": "J Adolesc Health", "authors": ["Glueck CJ", "Wang P", "Fontaine R", "Tracy T", "Sieve-Smith L"], "date": "2001-09-01T00:00:00Z", "doi": "10.1016/s1054-139x(01)00202-6", "meta_date_publication": "2001 Sep", "meta_volume": "29", "meta_issue": "3", "meta_pages": "160-9", "score": 50047.086, "text_hl": "CONCLUSION: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ safely ameliorates the @<m>DISEASE_Alopecia_Neurologic_Defects_and_Endocrinopathy_Syndrome</m> @DISEASE_MESH:C567425 @@@endocrinopathy@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ in previously oligo-amenorrheic teenage females with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, facilitating resumption of normal menses in most @SPECIES_9606 @@@girls@@@.", "citations": {"NLM": "Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health. 2001 Sep;29(3):160-9. PMID: 11524214", "BibTeX": "@article{11524214, title={Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).}, author={Glueck CJ and Wang P and Fontaine R and Tracy T and Sieve-Smith L}, journal={J Adolesc Health}, volume={29}, number={3}, pages={160-9}}"}}]}